• Intratracheal Budesonide for Extremely Preterm Infants

  • Nov 11 2024
  • Length: 8 mins
  • Podcast

Intratracheal Budesonide for Extremely Preterm Infants

Listen for free

View show details

  • Summary

  • Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women’s Hospital, Melbourne, Australia, discusses a new study of the effect of intratracheal corticosteroid administration on survival free of bronchopulmonary dysplasia in preterm infants, with JAMA Deputy Editor Tracy A. Lieu, MD, MPH.

    Related Content:

    • Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants
    Show More Show Less
Show More Show Less

What listeners say about Intratracheal Budesonide for Extremely Preterm Infants

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.